Results 121 to 130 of about 9,776 (201)

[Research progress of molecular imprinting technology in the field of disease diagnosis and therapy]. [PDF]

Se Pu
Zhu R, Cai GP, Zheng HJ, Jia Q.
europepmc   +1 more source

B 7 修饰的肿瘤细胞疫苗体内外抗肿瘤作用

Zhongshan Daxue xuebao. Yixue kexue ban, 1998
目的: 研究小鼠 B7 修饰的肿瘤细胞疫苗的体内外抗肿瘤作用。 方法: 应用逆转录病毒载体, 将小鼠 B 7-1 和 B7-2 导入小鼠肝癌细胞 Hepal-6细胞株中, G418 筛选后获高表达 B7 分子的阳性细胞克隆,经丝裂霉素处理制备成肿瘤细胞 疫苗( TCV) ,观察 TCVB7体外刺激的脾细胞对不同肿瘤细胞系的抗瘤活性及对不同动物模型的体内免疫保护作用和免疫治疗 作用。结果: ①TCVB7体外刺激的脾细胞对亲本肝癌细胞和小鼠 NK 敏感的 Yac-1细胞的体外细胞毒作用明显增强; ②在免疫 ...
doaj  

[SERPINE1 overexpression promotes proliferation and paclitaxel resistance of triple-negative breast cancer cells by inducing M2 macrophage polarization]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhang Q, Liu B, Lei L, Wang Y, Zhang X, Mao Z, Tang P, Zhang J, Yang J, Peng Y, Liu Z.   +10 more
europepmc   +1 more source

1, 2, 3-三氮唑[4, 5- d ]嘧啶衍生物的合成及抗肿瘤活性评价

, 2018
Nannan Li, Jin Xin, Q. Ma, Erdong Li, Y. Meng, Chongnan Bao, Peng Yang, Panpan Song, Fei Cui, Peng Cheng, Yifei Gu, Pei Zhao, Y. Ke, Hongmin Liu, Qiurong Zhang   +14 more
semanticscholar   +1 more source

[A case report of retroperitoneal infantile fibrosarcoma with <i>RBPMS-NTRK3</i> fusion gene positivity]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Zhou XY, Jiang J, Wang LZ, Guo JH.
europepmc   +1 more source

[Nasopharyngeal carcinoma in children: clinical analysis of 6 cases and literature review]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Tang ML, Zhang WL, Wang YZ, Zhang Y.
europepmc   +1 more source

2,4,6-三取代嘧啶衍生物的合成及体外抗肿瘤活性研究

, 2017

semanticscholar   +1 more source

[Current status and future directions of stability reconstruction following spinal tumor resection]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Zhou J, Dong J.
europepmc   +1 more source

喹唑啉-4-酮衍生物的合成及抗肿瘤活性

, 2017
Jiajing Sun, Likai Zhou, Guanhai Tan, Shuai Li, Shuxiao Wang, Huatang Chen, Xiaoli Li   +6 more
semanticscholar   +1 more source

[Overexpression of lncRNA SNHG12 promotes docetaxel resistance of prostate cancer cells by activating PI3K/AKT signaling <i>via</i> interacting with ELAVL1]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhao C, Li W, Zheng B, Wang G, Xiao Z, Li Y.   +5 more
europepmc   +1 more source